BGM Group Ltd. , a leading AI technology company, today announced it has entered into a definitive agreement (the 'Agreement') to acquire HM Management Company Limited ('HM Management'), a prominent AI agent production platform, in an all-stock transaction valued at approximately RMB300 million (US$41.7 million)..

BGM集团有限公司，一家领先的人工智能技术公司，今天宣布已达成一项最终协议（“协议”），将以全股票交易方式收购知名人工智能代理生产平台HM管理有限公司（“HM管理”），交易估值约为人民币3亿元（4170万美元）。

Under the Agreement, BGM will issue 16,663,427 Class A ordinary shares at $2.50 per share to acquire 100% ownership of HM Management and its two wholly-owned subsidiaries: Beijing Shuda Technology Company Limited. ('Shuda Technology') and New Media Star Technology (Shenzhen) Co., Ltd ( 'New Media Star').

根据协议，BGM将发行16,663,427股A类普通股，每股2.50美元，以收购HM Management及其两家全资子公司：北京数达科技有限公司（“数达科技”）和新媒体之星技术（深圳）有限公司（“新媒体之星”）的100%所有权。

The transaction is expected to close in the second quarter of 2025, subject to customary closing conditions..

该交易预计将在2025年第二季度完成，但需满足惯例的交割条件。

Shuda Technology is a high-tech company specializing in AI-driven enterprise efficiency solutions. By delivering integrated AI and data visualization solutions, it empowers businesses to conduct intelligent, end-to-end diagnostics and enhance decision-making across the entire innovation chain from research and development to commercialization, enabling rapid cost reduction, operational efficiency improvement, and business model innovation.

数达科技是一家专注于人工智能驱动的企业效率解决方案的高科技公司。通过提供集成的人工智能和数据可视化解决方案，它赋能企业进行智能化的端到端诊断，并提升从研发到商业化的整个创新链条中的决策能力，助力快速降低成本、提高运营效率并实现商业模式创新。

New Media Star operates a fast-growing AI tools platform with over 150,000 followers, offering proprietary and third-party AI solutions for customer acquisition and private domain conversion..

新媒星运营一个快速增长的 AI 工具平台，拥有超过 15 万名粉丝，提供用于客户获取和私域转化的自主及第三方 AI 解决方案。

Xin Chen, Chief Executive Officer of the Company, stated: 'The addition of Shuda Technology and New Media Start introduces a disruptive engine to our strategy of building a multi-agentic production platform. Their matrix-based vertical industry agent cloning technology and AI visualization engine address a critical strategic gap, enabling us to foster technological creativity and drive industry-wide impact.

陈鑫，公司首席执行官，表示：“随着数达科技和新媒体星的加入，为构建多智能体生产平台的战略引入了一个颠覆性的引擎。他们基于矩阵的垂直行业智能体克隆技术和人工智能可视化引擎填补了一个关键的战略空白，使我们能够促进技术创造力并推动全行业的影响力。”

This acquisition enhances our industry-specific AI DNA, allowing us to rapidly expand into vast market opportunities and create a leading ecosystem of AI agent applications. Their portfolio of over 100 industry-specific AI modules, along with an established developer ecosystem, will significantly accelerate our roadmap and secure a dominant position in the next-generation industry-specific AI operating systems.'.

这次收购增强了我们特定于行业的AI基因，使我们能够迅速拓展广阔的市场机遇，并创建一个领先的AI代理应用生态系统。他们拥有超过100个行业特定的AI模块组合以及成熟的开发者生态系统，将大大加速我们的路线图，并确保我们在下一代行业特定AI操作系统中占据主导地位。

The acquisition expands the Company's AI application portfolio and further integrates existing market resources from its AI insurance and AI mobility businesses, further solidifying the Company's position in the AI industry.

此次收购扩大了公司的AI应用组合，并进一步整合了其AI保险和AI移动业务的现有市场资源，进一步巩固了公司在AI行业的地位。

About BGM Group Ltd.

关于BGM集团有限公司

BGM Group Ltd. has a strategic focus on the technology fields of AI application, intelligent robots, algorithmic computing power, cloud computing, and biopharmaceuticals.

BGM集团有限公司战略布局人工智能应用、智能机器人、算法算力、云计算、生物医药等技术领域。

In terms of AI application implementation, the group relies on advanced analytics and AI Agent technology, and utilizes the two platforms of Du Xiao Bao and Bao Wang to provide comprehensive and professional AI solutions and intelligent robot services for insurance companies, insurance brokers, and consumers.

在人工智能应用落地方面，集团依托领先的高级分析及AI Agent技术，利用度小保及宝旺两大平台，为保险公司、保险经纪以及消费者提供全面专业的AI解决方案及智能机器人服务。

Its services cover multiple key scenarios such as sales and marketing, underwriting assessment, claims processing, and customer service. The group is capable of analyzing consumer data, building consumer profiles, accurately predicting insurance needs, and providing highly customized services for consumers..

其服务覆盖销售与营销、核保评估、理赔处理及客户服务等多个关键场景，能够分析消费者数据、构建消费者画像、精准预测保险需求，并为消费者提供高度定制化的服务。

In the field of biopharmaceuticals, the group's biopharmaceutical division mainly produces oxytetracycline API, crude heparin sodium, and licorice preparations, which are widely supplied to the global animal husbandry, pharmaceutical, and drug retail markets. The group deeply integrates AI-assisted decision-making into every link of production and manufacturing, achieving supply chain optimization, process efficiency improvement, and market trend prediction.

在生物制药领域，集团的生物制药部门主要生产土霉素原料药、粗品肝素钠和甘草制剂，广泛供应给全球畜牧业、医药和药品零售市场。集团深度融合人工智能辅助决策于生产和制造的每一个环节，实现供应链优化、工艺效率提升和市场趋势预测。

This provides scientific decision-making basis for the management and offers high-quality products and precise services for consumers..

这为管理提供了科学的决策依据，为消费者提供了优质的产品和精准的服务。

Forward-looking Statements

前瞻性声明

This news release contains forward-looking statements within the meaning of Section 21E of the Securities Exchange Act of 1934, as amended, and as defined in the U.S. Private Securities Litigation Reform Act of 1995. These forward-looking statements can be identified by terminology such as 'will', 'expects', 'anticipates', 'future', 'intends', 'plans', 'believes', 'estimates', 'target', 'going forward', 'outlook' and similar statements.

本新闻稿包含根据修订后的1934年《证券交易法》第21E条以及1995年《美国私人证券诉讼改革法》定义的前瞻性陈述。这些前瞻性陈述可以通过诸如“将”、“预计”、“预期”、“未来”、“打算”、“计划”、“相信”、“估计”、“目标”、“展望”以及类似的术语来识别。

Such statements are based upon management's current expectations and current market and operating conditions and relate to events that involve known or unknown risks, uncertainties and other factors, all of which are difficult to predict and many of which are beyond the Company's control, which may cause the Company's actual results, performance or achievements to differ materially from those in the forward-looking statements.

此类声明基于管理层的当前预期以及当前的市场和经营状况，涉及已知或未知的风险、不确定性和其他因素的事件，所有这些因素都难以预测，且其中许多超出公司的控制范围，可能导致公司的实际结果、业绩或成就与前瞻性声明中的内容存在重大差异。

Further information regarding these and other risks, uncertainties or factors is included in the Company's filings with the U.S. Securities and Exchange Commission. The Company does not undertake any obligation to update any forward-looking statement as a result of new information, future events or otherwise, except as required under law..

有关这些及其他风险、不确定性或因素的更多信息，请参阅公司向美国证券交易委员会提交的文件。除非法律另有要求，公司不承担因新信息、未来事件或其他原因而更新任何前瞻性陈述的义务。

For investor and media inquiries, please contact:

投资者和媒体咨询，请联系：

info@qiliancorp.com

info@qiliancorp.com

Source: prnewswire.com

来源：prnewswire.com